More than 1,500 aesthetic surgeons and specialists in the fields of anti-aging and regenerative medicine from around the globe will attend the four day event.
Charles Mahl, M.D. and David B. Audley will representGlobal Stem Cells Group, Inc. as keynote speakers at the 15th International Congress of Aesthetic Surgeryin Boca del Rio in Veracruz, Mexico July 9-12, 2015. Mahl, a member of the Global Stem Cells Group Scientific Advisory Board, and Audley, the chairman and general secretary of the Regentech Alliance (RTA), will join more than 1,500 aesthetic surgeons and specialists in the fields of anti-aging and regenerative medicine from around the globe for the four day event.
Hosted by the Instituto de Estudios Superiores en Medicina (Institute of Advanced Studies in Medicine) in Veracruz, conference attendees will include an international lineup of physicians and medical practitioners in a variety of disciplines who will gather to discuss the newest therapies, protocols and innovative procedures available in aesthetic medicine.
Mahl, who maintains an active practice in regenerative medicine, preventive aging and pain therapies, will bring his expertise in prolotherapy, platelet rich plasma injections and stem cell therapies to the conference. Audley is a pioneer in the field of regenerative medicine and the founding executive director of the International Cellular Medicine Society (ICMS), the first professional medical association dedicated to the development of standards and accreditation for medical facilities engaged in cell-based therapies.
The conference will feature workshops in botulinum toxin applications for beginners and advanced students, and peeling treatments for stretch marks. Some of the topics to be addressed at the event include updates in aesthetic surgery, regenerative medicine therapies, platelet rich plasma applications, clinical and therapeutic stem cell applications, facial fillings, COFEPRIS guidelines, legal issues associated with aesthetic surgery and more.
The conference will take place at the Hotel Galerias Plaza Veracruz, Blvd. Adolfo Ruiz Cortines #3495, Costa Verde, Boca Del Río, Veracruz. For more information on the 15th International Congress of Aesthetic Surgery, visit the Global Stem Cells Group website, email bnovas(at)stemcellsgroup(dot)com or call 305-560-5337.
About Global Stem Cell Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
About Charles Mahl, M.D.:
Charles F. Mahl, M.D. is a Miami-based specialist in regenerative medicine, preventive aging and pain therapies. His expertise includes prolotherapy, platelet rich plasma injections and stem cell therapies for a variety of painful orthopedic conditions and injuries involving (but not limited to) the back, sacroiliac joints, hips, knees, shoulders and neck. Mahl’s background as a vitreo-retinal surgeon prior to his training in regenerative medicine makes him eminently qualified to perform stem cell therapies on the eyes.
A member of the Global Stem Cells Group Scientific Advisory Board, Mahl sees stem cell therapies as medicine’s new frontier, offering unlimited possibilities for easing and eliminating many forms of disease and injury-related pain. He is licensed to practice medicine in Florida and Board Certified in Integrative Medicine. Mahl has completed multiple fellowships in age management medicine, and spent more than two years in a mentorship program for prolotherapy and regenerative injection medicine with Alvin Stein, M.D., a relationship that continues to this day. For Mahl’s full bio, visit http://www.stemcellsgroup.com/advisory-board/.
About David B. Audley:
David B. Audley serves as the Chair and General Secretary of the Regentech Alliance (RTA), a 501(c)3 backed by individuals and institutions who support the Regentech mission to bring peer oversight and transparency to the field of cell-based and regenerative medicine. Audley is a pioneer in the emerging field of regenerative medicine, and the founding executive director of the International Cellular Medicine Society (ICMS), the first professional medical association dedicated to the development of standards and accreditation for medical facilities engaged in cell-based therapies. Audley has taken a leadership role in drafting international standards and governmental regulations for the Cayman Islands and the Bahamas, and has worked with regulators in Mexico, the Kingdom of Jordan, and China to provide frameworks for physicians. Audley is a well-known lecturer who has spoken widely on varying topics dealing with the trends in patient care, the importance of oversight for investigational therapies, the emergence of regenerative medicine and the global and regulatory issues associated with medical tourism. For more information, visit http://regen-tech.org.
